Table 3.
Procedural and in-hospital results of patients submitted to trans-apical and trans-axillary TAVI Approach in our Institution.
| Trans-apical | Trans-axillary | |
|---|---|---|
| Patients (n) | 15 | 15 |
| Hospital stay (days), mean ± SD | 15.8 ± 4.8 | 8.7 ± 1 |
| Procedural success, n (%) | 13 (86.6) | 14 (93.3) |
| Need for permanent pacemaker, n (%) | 3 (20) | 1 (6.7) |
| Neurological events, n (%) | 1 (6.7) | 1 (6.7) |
| Acute renal failure requiring CVVH, n (%) | 4 (26.6) | 2 (13.3) |
|
| ||
| 30-day clinical outcome | ||
| Death, n (%) | 2 (13.3) | 0 |
| Cardiac death, n (%) | 2 (13.3) | 0 |
| LVEF (%), mean ± SD | 49.67 ± 10.4 | 52.73 ± 10.1 |
|
| ||
| Six-month cumulative clinical outcome | ||
| Death, n (%) | 4 (26.6) | 2 (18.2) |
| Cardiac death, n (%) | 4 (26.6) | 1 (9.1) |
| LVEF (%), mean ± SD | 56.22 ± 4.12 | 60.23 ± 3.45 |
SD: standard deviation; CVVH: continuous venovenous hemofiltration; LVEF: left ventricle ejection fraction.